• Bar H, Yacoby I, Benhar I, 2008: Killing cancer cells by targeted drug-carrying phage nanomedicines. BMC Biotechnol 8, 37.
  • Brigati JR, Petrenko VA, 2005: Thermostability of landscape phage probes. Anal Bioanal Chem 382, 13461350.
  • Brigati J, Samoylova TI, Jayanna P, Petrenko V, 2008: Phage display for generating peptide reagents. In: Coligan JE, Dunn BM, Speicher DW, Wingfield PT, Taylor GP (eds), Current Protocols in Protein Science, Vol. 3, Unit 18.9. John Wiley & Sons, Inc., USA, pp.
  • De Berardinis P, Sartorius R, Caivano A, Mascolo D, Domingo GJ, Del Pozzo G, Gaubin M, Perham RN, Piatier-Tonneau D, Guardiola J, 2003: Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection. Curr HIV Res 1, 441446.
  • Eriksson F, Tsagozis P, Lundberg K, Parsa R, Mangsbo SM, Persson MA, Harris RA, Pisa P, 2009: Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages. J Immunol 182, 31053111.
  • Frenkel D, Dewachter I, Van Leuven F, Solomon B, 2003: Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization. Vaccine 21, 10601065.
  • Hermanson GT, 1996: Zero-length cross-linker. In: Hermanson GT (ed.), Bioconjugate Techniques. Academic Press, Salt Lake City, pp. 169186.
  • Houimel M, Dellagi K, 2009: Peptide mimotopes of rabies virus glycoprotein with immunogenic activity. Vaccine 27, 46484655.
  • van Houten NE, Zwick MB, Menendez A, Scott JK, 2006: Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide. Vaccine 24, 41884200.
  • Jung MJ, Moon YC, Cho IH, Yeh JY, Kim SE, Chang WS, Park SY, Song CS, Kim HY, Park KK, McOrist S, Choi IS, Lee JB, 2005: Induction of castration by immunization of male dogs with recombinant gonadotropin-releasing hormone (GnRH)-canine distemper virus (CDV) T helper cell epitope p35. J Vet Sci 6, 2124.
  • Khan MA, Ogita K, Ferro VA, Kumasawa K, Tsutsui T, Kimura T, 2008: Immunisation with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes in saline suppresses rodent fertility. Vaccine 26, 13651374.
  • Kirkpatrick JF, Lyda RO, Frank KM, 2011: Contraceptive vaccines for wildlife: a review. Am J Reprod Immunol 66, 4050.
  • Manoutcharian K, Gevorkian G, Cano A, Almagro JC, 2001: Phage displayed biomolecules as preventive and therapeutic agents. Curr Pharm Biotechnol 2, 217223.
  • Miller LA, Johns BE, Killian GJ, 2000: Immunocontraception of white-tailed deer with GnRH vaccine. Am J Reprod Immunol 44, 266274.
  • Petrenko VA, Smith GP, 2005: Vectors and modes of display. In: Sidhu S (ed.), Phage Display in Biotechnology and Drug Discovery. CRC Press, Taylor & Francis Group, Boca Raton, London, New York, Singapore, pp. 63110.
  • Turkstra JA, Oonk HB, Schaaper WM, Meloen RH, 2001: The role of the individual amino acids of a GnRH-tandem-dimer peptide used as an antigen for immunocastration of male piglets determined with systematic alanine replacements. Vaccine 20, 406412.
  • Wang G, Sun M, Fang J, Yang Q, Tong H, Wang L, 2006: Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice. Vaccine, 24, 60656073.